EDAP TMS S.A. (EDAP) Analysts See $-0.02 EPS

August 13, 2018 - By Eula Gilbert


Analysts expect EDAP TMS S.A. (NASDAQ:EDAP) to report $-0.02 EPS on August, 30 before the open.They anticipate $0.03 EPS change or 60.00 % from last quarter’s $-0.05 EPS. After having $0.03 EPS previously, EDAP TMS S.A.’s analysts see -166.67 % EPS growth. The stock decreased 0.95% or $0.03 during the last trading session, reaching $3.14. About 19,347 shares traded. EDAP TMS S.A. (NASDAQ:EDAP) has declined 14.64% since August 13, 2017 and is downtrending. It has underperformed by 27.21% the S&P500.

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company has market cap of $91.05 million. The firm operates in two divisions: High Intensity Focused Ultrasound , and Urology Devices and Services (UDS). It currently has negative earnings. The HIFU division develops, makes, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology.

More news for EDAP TMS S.A. (NASDAQ:EDAP) were recently published by: Benzinga.com, which released: “40 Biggest Movers From Yesterday” on July 17, 2018. Nasdaq.com‘s article titled: “EDAP TMS SA : EDAP TMS SA to Announce Second Quarter 2018 Financial Results on Thursday, August 30” and published on July 24, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.